Navigation Links
BONESUPPORT Selected As A 2012 Red Herring Top 100 Global
Date:12/6/2012

LUND, Sweden, Dec. 6, 2012 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that it has been selected as a Top 100 Winner for Red Herring's 2012 Global Award in recognition as a leader in innovation and technology among private companies from North America, Europe and Asia.  Red Herring's Top 100 Global list has become a mark of distinction for identifying promising new companies and entrepreneurs.

(Photo: http://photos.prnewswire.com/prnh/20121206/NY24527 )

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of Global candidates to the Top 100 Winners. We believe BONESUPPORT embodies the vision, drive and innovation that define a successful entrepreneurial venture. BONESUPPORT should be proud of its accomplishment, as the competition was the strongest it has ever been."

Red Herring's editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technology innovation, management quality, strategy, and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their peers, allowing Red Herring to see past the "buzz" and make the list a valuable instrument of discovery and advocacy for the most promising new business models from around the world.

"This is a great distinction for BONESUPPORT as we continue to focus our efforts on global commercialization of our platform technology CERAMENT™," said Lloyd Diamond, CEO of BONESUPPORT. "This award will help to further build awareness of our innovative technology and I am pleased that we have been recognized in this way."

About Red Herring
Red Herring is a global media company uniting the world's best high-technology innovators, venture investors, and business decision-makers in a variety of forums:  a leading innovation magazine, an online daily technology news service technology newsletters, and major events for technology leaders around the globe.  Red Herring provides an insider's view of the global innovation ecosystem, featuring unparalleled insights on the emerging technologies driving the economy.

About BONESUPPORT
BONESUPPORT is an emerging leader of injectable bone substitutes for orthopedic trauma focusing on bone infection, instrument augmentation related to orthopedic surgery and spinal applications.

CERAMENT™ is an injectable, synthetic bone substitute that mimics the properties of cancellous bone, allows for controlled resorption to support future bone ingrowth and is injectable under local anesthesia for minimally invasive surgery. CERAMENT's unique biologic properties deliver a consistent, pre-packed and ready-to-use formulation to facilitate optimal delivery.

CERAMENT™ is a fully developed product platform that is commercially available in the U.S. and Europe and is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT spans more than eleven years and over forty-five pre-clinical, clinical and animal studies have been conducted. More than 4,000 patients have been treated with CERAMENT.  The company was founded in 1999 and is based in Lund, Sweden with subsidiary locations in the US and Germany. To learn more about BONESUPPORT please visit www.bonesupport.com.

Press Inquiries:
Offer Nonhoff
Chief Financial Officer
Offer.Nonhoff@bonesupport.com
Phone +46 46 286 53 60


'/>"/>
SOURCE BONESUPPORT
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. The IPCC Report on Climate Change - Swedish professor Thomas Sterner selected as 1 of the experts
2. Aware Announces Closing Of Sale Of Selected Patents
3. Aware Announces Sale of Selected Patents
4. University of Texas Medical Branch selected to manage Center for Polar Medical Operations
5. Carnegie Mellon Universitys Biometrics Center Selected To House New Pedo-Biometrics Research and Identity Automation Lab
6. Duke selected to receive multi-million dollar grant for HIV vaccine
7. 2 NASA visualizations selected for computers graphics showcase
8. 22 of Americas most promising scientists selected as Pew Biomedical Scholars
9. UNCs Saskia Neher selected as 2012 Pew Scholar
10. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
11. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017 Agenus Inc. (NASDAQ: ... checkpoint antibodies and cancer vaccines, today announced participation at ... th  Annual William Blair and Maidstone Life Sciences conference ... Center in New York, NY . ... March 29 at 9:40 am: Robert B. Stein ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen Matloff, president and ... Council (CTC) as a 2017 Women of Innovation® finalist. Matloff will be among ... Dinner. , The dinner recognizes women accomplished in science, technology, engineering and math ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
Breaking Biology Technology: